Skip to main content
OpenTrials
Completed

NCT Number: NCT04046731

Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation

The researchers are trying to develop an allergy skin test to help predict allergic responses to medications commonly given to patients during surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Allergy Hypersensitivity Immune System Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic

Jacksonville, Florida, 32224, United States

About this study

This study will be a prospective study to accurately determine the negative predictive value of skin testing with NMBAs.

It is hypothesized that the concentrations that should be used for NMBAs are actually much lower than previously recommended and that the higher incidence of identifiable NMBA induced allergic reactions during anesthesia in the past may be due to irritation of the skin rather than a true allergic reaction (false positives).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All adults > or = to 18 y/o undergoing surgery

Exclusion criteria

  • Minors under the age of 18 y/o, Adults unable to consent, or those Adults with previous allergic reaction history during previous surgeries.

Treatment and study plan

skin testing

Diagnostic Test

Percutaneous skin prick followed by Intradermal Injections of NMBAs at increasing concentrations compared with an established positive and negative control.

Primary outcomes

  1. Non-Irritant Concentrations to common NMBAs

    Time frame: 1 Year

    Determine the NIC to common NMBAs

Secondary outcomes

  1. Negative Predictive Value of Intradermal Skin Testing to commonly used NMBAs

    Time frame: 1 Year

    Determine Negative Predictive Value of Intradermal Skin Testing to commonly used NMBAs

  2. Max Concentration used when skin testing to NMBAs

    Time frame: 1 Year

    Close gap on the variability of the maximal concentration used when skin testing NMBAs.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

The Negative Predictive Value and Non-irritant Skin Testing Concentrations of Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Aug 6, 2019
Registry last updated
Feb 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.